Litcius/Paper detail

Benefit from pemigatinib in cholangiocarcinoma

Diana Romero

2020Nature Reviews Clinical Oncology21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineGeneral surgeryCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersPeptidase Inhibition and Analysis
Benefit from pemigatinib in cholangiocarcinoma | Litcius